Virbac's first half 2021 figures are now out.
"companion animal activities grew by +24.3% overall ... essentially driven by the remarkable double digit growth of the specialty ranges (including Clomicalm, Movoflec, Stelfonta)..."
interesting.
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-443
-
- There are more pages in this discussion • 832 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)